How Does Chloroform Work? Its Mechanism and Effects

Chloroform produces unconsciousness primarily by enhancing the activity of inhibitory signaling in the brain while simultaneously dampening excitatory signaling, tipping the balance so far toward neural quietness that awareness and sensation shut down. For over a century after its first use as an anesthetic in 1847, the precise molecular targets were debated, but modern research points to a handful of specific proteins embedded in nerve-cell membranes as the key sites of action. The story of how chloroform works is also, unavoidably, a story of how it harms: the same chemical properties that let it knock you out make it dangerous to the heart, liver, and kidneys.

The Shift from Membranes to Proteins

Scientists noticed early on that anesthetic potency correlates tightly with how well a substance dissolves in fat. This observation, known as the Meyer-Overton correlation, dominated thinking for decades and led to the assumption that chloroform and similar agents worked by dissolving into the fatty membranes surrounding nerve cells, physically disrupting their structure enough to block signaling. It was a tidy explanation, but it could not account for why some very fat-soluble compounds have no anesthetic effect at all, or why tiny structural changes to a molecule could flip its activity on or off.

With the arrival of more precise laboratory tools, the focus shifted. Researchers could now isolate individual proteins in cell membranes and test whether anesthetics interacted with them directly. The result was a widespread shift in the field: proteins, specifically receptors and ion channels, are now accepted as the more likely targets for anesthetic action rather than the lipid membrane itself.

1PubMed Central. Anaesthetic mechanisms: update on the challenge of unravelling the mystery of anaesthesia

What Chloroform Does Inside the Brain

Your brain balances excitatory signals (which keep neurons firing) against inhibitory signals (which calm them down). Chloroform shifts the balance toward inhibition in at least two ways. First, it enhances the function of GABA-A receptors, the main “off switch” in the central nervous system. When chloroform binds to these receptors, the inhibitory current they produce becomes stronger and lasts longer, making it harder for neurons to fire. Second, chloroform interferes with excitatory receptors, reducing the signals that would normally keep you awake and responsive. The combined effect is a progressive shutdown: first awareness fades, then the ability to sense pain, and eventually the reflexes that keep you breathing.

Beyond GABA-A receptors, chloroform also activates certain potassium channels. One well-studied example is the TREK-1 channel, a type of “leak” channel that allows potassium ions to flow out of neurons, making them less excitable. Laboratory studies have shown that chloroform reversibly activates these channels at concentrations consistent with clinical anesthesia.

2PubMed. A TREK-1-like potassium channel in atrial cells inhibited by beta-adrenergic stimulation and activated by volatile anesthetics

Opening more potassium channels hyperpolarizes the neuron, pushing it further from its firing threshold. This is essentially another route to the same outcome: quieter neurons and a deeper state of unconsciousness.

Why Chloroform Is So Dangerous to the Heart

The same affinity for ion channels that makes chloroform effective at silencing brain activity also makes it hazardous to the heart. Cardiac cells rely on carefully timed waves of sodium, potassium, and calcium ions to keep a steady rhythm. Chloroform interacts with several of these cardiac ion channels at once, particularly the hERG potassium channel, which controls a major phase of the heartbeat’s electrical recovery.

When chloroform blocks or alters hERG and other repolarizing channels, the shape of each heartbeat’s electrical signal changes in a way that makes the heart vulnerable to dangerous rhythm disturbances. The effect is made worse by stress hormones like adrenaline. In the presence of both chloroform and elevated catecholamines, the heart is far more likely to develop triggered abnormal beats and potentially lethal arrhythmias.

3PubMed. Mechanisms involved in cardiac sensitization by volatile anesthetics: general applicability to halogenated hydrocarbons?

This phenomenon, called cardiac sensitization, was one of the earliest recognized hazards of chloroform anesthesia. A patient might be under anesthesia uneventfully, then experience a surge of adrenaline from a painful stimulus or simple fear, and go into cardiac arrest within seconds. It explains the seemingly random pattern of sudden deaths that plagued chloroform’s early clinical use.

The Historical Death Toll

James Young Simpson first demonstrated chloroform’s anesthetic properties on himself in November 1847, and word spread fast.

4PubMed. History of chloroform anesthesia Within months it was in wide use across Britain and continental Europe. But reports of sudden deaths followed almost as quickly. The first recorded fatality was a 15-year-old girl named Hannah Greener, who died under chloroform on January 28, 1848, barely three months after Simpson’s demonstration.

Despite the mounting death reports, chloroform’s popularity soared. Between roughly 1865 and 1920, it was used in an estimated 80 to 95 percent of all anesthesia procedures in the United Kingdom and German-speaking countries. A compilation of all available statistics up to 1934 showed the risk: fatal complications under chloroform occurred at a rate of roughly 1 in 3,000 to 1 in 6,000, compared with 1 in 14,000 to 1 in 28,000 for ether.

4PubMed. History of chloroform anesthesia

Put differently, chloroform was roughly three to five times more likely to kill a patient than its main competitor. The cardiac sensitization mechanism described above accounts for a large share of those deaths, though liver failure and respiratory depression also contributed.

How the Body Breaks Down Chloroform and Why That Matters

Once chloroform enters the bloodstream, the liver begins processing it using a family of enzymes, primarily one called CYP2E1.

5PubMed. The metabolic rate constants and specific activity of human and rat hepatic cytochrome P-450 2E1 toward toluene and chloroform This enzyme oxidizes chloroform into an intermediate compound called trichloromethanol, which is unstable and quickly falls apart into phosgene, a highly reactive molecule.6Drug Metabolism and Disposition: the Biological Fate of Chemicals. Metabolism of Chloroform in the Human Liver and Identification of the Competent P450s If you recognize the name phosgene from its use as a chemical weapon in World War I, that recognition is appropriate. It is extremely toxic to cells.

In small amounts, the body can neutralize phosgene before it does much damage, mainly by reacting it with glutathione, a natural antioxidant found in every cell. But when exposure is large or sustained, the glutathione supply runs out faster than it can be replenished. Once that protective buffer is gone, phosgene attacks proteins and other cellular structures directly. This is the fundamental reason that chloroform exposure, whether through inhalation or ingestion, can injure internal organs: it is not the chloroform itself that does the worst damage, but the toxic byproduct the body creates while trying to get rid of it.

Liver Damage from Chloroform

Because the liver is the primary site of chloroform metabolism, it bears the brunt of phosgene-related damage. Research on isolated liver cells has mapped out the sequence in detail. In the first phase, glutathione levels drop as the cell tries to mop up phosgene. The degree of depletion tracks directly with the dose and duration of exposure.

7Toxicology Letters. The mechanism of chloroform toxicity in isolated rat hepatocytes

Once glutathione is depleted, a second phase begins. Mitochondria, the cell’s energy factories, lose their ability to maintain their internal barrier, a process researchers call the mitochondrial permeability transition. Reactive oxygen and nitrogen species accumulate, proteins get damaged, and the cell eventually dies.

8PubMed. Mechanisms of chloroform-induced hepatotoxicity: oxidative stress and mitochondrial permeability transition in freshly isolated mouse hepatocytes In a living person, this process shows up as elevated liver enzymes in blood tests and, in severe cases, outright liver failure. People who already have compromised liver function or who drink heavily are especially vulnerable because alcohol consumption ramps up CYP2E1 activity, potentially generating more phosgene from a given dose of chloroform.

Kidney Damage Works Through the Same Enzyme

The kidneys are another major target. For years it was assumed that liver-generated phosgene traveled through the bloodstream to the kidneys and damaged them there. But studies using genetically modified mice that lacked CYP2E1 in the liver found something surprising: even without any liver metabolism of chloroform, kidney damage still occurred.

9PubMed Central. Mechanism of chloroform-induced renal toxicity: non-involvement of hepatic cytochrome P450-dependent metabolism

The kidneys have their own supply of CYP2E1 and related enzymes, and they produce phosgene locally. Further experiments confirmed this by examining mice whose kidney-specific enzyme activity was knocked out; those animals showed far less kidney injury after chloroform exposure.

10PubMed Central. The role of renal proximal tubule P450 enzymes in chloroform-induced nephrotoxicity: utility of renal specific P450 reductase knockout mouse models

The practical takeaway is that chloroform can injure the kidneys independently of what happens in the liver. Damage shows up in the proximal tubules, the sections of the tiny kidney tubes where most reabsorption happens. In severe cases this leads to measurable increases in blood urea nitrogen and creatinine, markers of failing kidney filtration.

Cancer Risk and Chronic Exposure

Low-level chloroform exposure happens more widely than most people realize. Chloroform is one of the byproducts formed when chlorine-based disinfectants react with organic matter in drinking water.

11PubMed. Formation of chloroform during chlorination of alanine in drinking water Concentrations in treated tap water are typically very low, measured in parts per billion, but the question of whether even small chronic exposures raise cancer risk has been studied extensively in animal models.

In long-term inhalation studies with mice and rats, chloroform exposure produced kidney and liver tumors in mice, with clear dose-response relationships. Male mice developed kidney tumors, and female mice developed liver tumors. Rats, interestingly, were more resistant; no significant increase in kidney or liver tumors was seen in rats at the same exposure levels.

12Journal of Occupational Health. Carcinogenicity and Chronic Toxicity in Rats and Mice Exposed to Chloroform by Inhalation

How the chloroform is delivered also matters. One striking finding was that mice given chloroform dissolved in corn oil by mouth developed liver tumors at very high rates, but mice given comparable doses in drinking water did not.

13Fundamental and Applied Toxicology. Carcinogenicity of chloroform in drinking water to male Osborne-Mendel rats and female B6C3F1 mice This suggests that the way chloroform arrives at the liver, whether in a sudden bolus or a slow trickle, changes the outcome dramatically. A sudden large dose overwhelms the glutathione defense and causes cell death, triggering regenerative cell division that can promote tumor growth. A slow, dilute dose may be neutralized before enough damage accumulates. This distinction has shaped regulatory thinking about drinking-water standards, where the relevant exposure is chronic and dilute rather than acute and concentrated.

Why Chloroform Was Replaced

Chloroform’s toxicity profile made the search for alternatives a priority almost from the beginning. Safety problems with early agents, especially chloroform, drove research toward fluorinated ethers and hydrocarbons.

14BJA Education. Pharmacology of anaesthetic agents II: inhalation anaesthetic agents Halothane replaced chloroform in the mid-20th century and was an improvement, though it retained some capacity for liver toxicity and cardiac sensitization. It was in turn largely replaced by the fluorinated ethers used today: isoflurane, sevoflurane, and desflurane. These modern agents still work on many of the same receptor and ion-channel targets, but they are far less toxic to the liver and heart, their effects wear off faster, and their therapeutic index (the gap between a useful dose and a dangerous one) is much wider.

Nitrous oxide, often combined with one of these volatile agents, provides additional analgesia and allows lower doses of the primary anesthetic. Xenon gas has also shown excellent anesthetic properties with minimal toxicity, but its scarcity and cost keep it out of routine use.

The Hollywood Rag Myth

In movies and crime fiction, a villain presses a chloroform-soaked cloth over someone’s mouth and the victim crumples unconscious within seconds. In reality, inhaling chloroform vapors at concentrations that could produce unconsciousness would take several minutes of sustained breathing, not a brief whiff. The concentration needed is high, and the recipient would experience a burning sensation in the mouth and airways, irritation of the eyes, coughing, and strong resistance reflexes long before losing consciousness. A person actively struggling would be extremely difficult to subdue this way.

That does not mean the Hollywood scenario is harmless, just unrealistic. Someone forcibly exposed to chloroform vapors for several minutes could lose consciousness, but the dose required to achieve that reliably is close to the dose that causes respiratory depression or cardiac arrest. There is no safe margin to work with, which is exactly why medical professionals abandoned it as an anesthetic. The gap between “effective” and “lethal” is uncomfortably narrow.

Chloroform in Laboratory and Veterinary Settings

Despite its toxicity, chloroform has persisted in some specialized contexts. In laboratories, it remains a common solvent for chemical extractions and organic chemistry procedures. Workers handling it are advised to use fume hoods and minimize skin contact, since chloroform is absorbed readily through the skin as well as the lungs.

In veterinary research, chloroform was historically used for euthanasia of small animals. Studies comparing different euthanasia agents found that chloroform induced collapse in animals within about 19 seconds on average, slower than carbon dioxide but far faster than ether, which took over a minute.

15PubMed. The behaviour of chickens, mice and rats during euthanasia with chloroform, carbon dioxide and ether For certain species like chickens, chloroform was considered more aesthetically acceptable than COâ‚‚ because it produced less visible distress such as wing flapping. However, concern over both animal welfare and handler safety has led many institutions to phase out chloroform in favor of other methods. Current veterinary euthanasia guidelines in most countries either restrict or discourage its use, particularly because the handler’s inhalation risk in an enclosed space is real and hard to eliminate entirely.

Individual Vulnerability and Dose Variability

One of the persistent dangers of chloroform is how much individual sensitivity varies. Factors that increase CYP2E1 activity, including chronic alcohol use and certain genetic variants, can amplify the production of phosgene and raise the risk of organ damage at any given exposure level. People with pre-existing liver or kidney disease have less functional reserve to absorb the insult. Nutritional status matters too, since glutathione production depends on adequate intake of sulfur-containing amino acids found in protein-rich foods. Someone malnourished or fasting may have lower baseline glutathione levels and tolerate chloroform poorly.

Sex differences in susceptibility have been observed in animal studies, with male rodents often showing greater kidney vulnerability and females showing more liver effects at equivalent doses. Whether these patterns translate cleanly to humans remains unclear, partly because ethical constraints obviously prevent controlled human dosing studies. Most of what we know about chloroform toxicity in people comes from occupational exposure reports, forensic cases, and the historical anesthesia literature, all of which point in the same direction as the animal data but without the precision of controlled experiments.